"name","description","uuid:ID","id","identifier","instanceType","label","text"
"Age Criteria","The study age criterion","d6a9b213-3c40-4300-ae8c-6483d2bb85b6","EligibilityCriterion_1","1","EligibilityCriterion","","Subjects shall be between [min_age] and [max_age]"
"Pop Criteria","The study population criterion","9963608a-7412-44a0-bf60-acd092a7c401","EligibilityCriterion_2","2","EligibilityCriterion","","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)"
"Diag Criteria","The study diagnosis criterion","2e77367a-eeb8-450e-9445-ee84fd8c5d05","EligibilityCriterion_3","3","EligibilityCriterion","","[Activity1] score of 10 to 23"
"Previous Criteria","The previous xanomeline TTS criterion","c6da54ad-2152-4e40-ab6a-b0615ef8a0ce","EligibilityCriterion_4","9","EligibilityCriterion","","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline."
